company background image
INDOCO logo

Indoco Remedies NSEI:INDOCO Stock Report

Last Price

₹331.60

Market Cap

₹30.6b

7D

-4.4%

1Y

2.7%

Updated

13 Jul, 2024

Data

Company Financials +

Indoco Remedies Limited

NSEI:INDOCO Stock Report

Market Cap: ₹30.6b

Indoco Remedies Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Indoco Remedies
Historical stock prices
Current Share Price₹331.60
52 Week High₹415.00
52 Week Low₹286.60
Beta0.46
11 Month Change1.98%
3 Month Change-4.37%
1 Year Change2.68%
33 Year Change-25.08%
5 Year Change109.67%
Change since IPO530.82%

Recent News & Updates

Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

May 24
Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

Recent updates

Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

May 24
Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders

Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts

Jan 26
Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts

Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?

Jan 26
Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now

Sep 16
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now

Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly

May 21
Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly

Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Aug 31
Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Jul 04
Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50

Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Jul 02
Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly

Jun 10
Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly

Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Mar 25
Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?

Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price

Mar 09
Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price

What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?

Feb 22
What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?

Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?

Feb 07
Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?

Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 17
Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Is Indoco Remedies (NSE:INDOCO) A Risky Investment?

Dec 27
Is Indoco Remedies (NSE:INDOCO) A Risky Investment?

Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)

Dec 06
Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)

What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?

Nov 14
What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?

Investors Who Bought Indoco Remedies (NSE:INDOCO) Shares A Year Ago Are Now Up 66%

Oct 19
Investors Who Bought Indoco Remedies (NSE:INDOCO) Shares A Year Ago Are Now Up 66%

These 4 Measures Indicate That Indoco Remedies (NSE:INDOCO) Is Using Debt Reasonably Well

Sep 14
These 4 Measures Indicate That Indoco Remedies (NSE:INDOCO) Is Using Debt Reasonably Well

Indoco Remedies Limited (NSE:INDOCO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Aug 17
Indoco Remedies Limited (NSE:INDOCO) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

How Much Did Indoco Remedies'(NSE:INDOCO) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jul 19
How Much Did Indoco Remedies'(NSE:INDOCO) Shareholders Earn From Share Price Movements Over The Last Five Years?

Shareholder Returns

INDOCOIN PharmaceuticalsIN Market
7D-4.4%0.7%0.5%
1Y2.7%51.1%45.1%

Return vs Industry: INDOCO underperformed the Indian Pharmaceuticals industry which returned 51.1% over the past year.

Return vs Market: INDOCO underperformed the Indian Market which returned 45.1% over the past year.

Price Volatility

Is INDOCO's price volatile compared to industry and market?
INDOCO volatility
INDOCO Average Weekly Movement3.4%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.4%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.2%

Stable Share Price: INDOCO has not had significant price volatility in the past 3 months.

Volatility Over Time: INDOCO's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19456,000Sundeep Bambolkarwww.indoco.com

Indoco Remedies Limited manufactures, markets, and sells formulations and active pharmaceutical ingredients in India and internationally. It offers stomatological, gastrointestinal, respiratory, anti-infective, vitamin/mineral/nutrient, ophthal/ontological, antifungal, hormonal, dermatology, urological, anti-diabetic, gynaecological, lifestyle management, pain/analgesic, and cardiac products. The company also provides branded generics comprising analgesic tablets and topical preparations; anti-hypertensive; protein supplements; multivitamin tablets and syrups; antibiotic tablets, syrups, and injectables; oral rehydration powders; anti-haemorrhoidals; antacids; antihistaminic; etc. In addition, it provides analytical services, such as impurity profile, particle size analysis, polymorphism and compatibility studies, heavy metal analysis, extractables and leachables studies, lyophilization studies, reference and working standards, forced degradation studies, and chromatographic method development and validation services.

Indoco Remedies Limited Fundamentals Summary

How do Indoco Remedies's earnings and revenue compare to its market cap?
INDOCO fundamental statistics
Market cap₹30.57b
Earnings (TTM)₹984.70m
Revenue (TTM)₹18.17b

31.0x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
INDOCO income statement (TTM)
Revenue₹18.17b
Cost of Revenue₹5.59b
Gross Profit₹12.58b
Other Expenses₹11.60b
Earnings₹984.70m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Jul 23, 2024

Earnings per share (EPS)10.68
Gross Margin69.23%
Net Profit Margin5.42%
Debt/Equity Ratio59.0%

How did INDOCO perform over the long term?

See historical performance and comparison

Dividends

0.5%

Current Dividend Yield

14%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.